Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum

Marsel Mesulam, Pamela Shaw, Deborah C Mash, Sandra Weintraub

Research output: Contribution to journalArticle

225 Citations (Scopus)

Abstract

The cholinergic denervation in Alzheimer's disease (AD) provides the rationale for treatments with anticholinesterases. The presence of this cholinergic lesion is solidly established in advanced AD. Whether it also exists in early disease remains unsettled. This question was addressed with thioflavin-S histofluorescence to identify neurofibrillary tangles (NFT) and two tau antibodies (AT8, Alz-50) to identify pre-tangle cytopathology in the nucleus basalis, the source of cortical cholinergic innervation. Methods for the concurrent visualization of tauopathy and choline acetyltransferase were used to determine if the cytopathology was selectively located within cholinergic neurons. Five elderly index cases who had died at the stage of mild cognitive impairment (MCI) or early AD were identified by longitudinal neuropsychological and behavioral assessments. They were compared to 7 age-matched cognitively normal subjects. NFT and AT8 (or Alz-50) immunostaining in cholinergic nucleus basalis neurons existed even in the cognitively normal subjects. The percentage of tauopathy-containing nucleus basalis neurons was greater in the cognitively impaired and showed a significant correlation with memory scores obtained 1-18 months prior to death. These results show that cytopathology in cortical cholinergic pathways is a very early event in the course of the continuum that leads from advanced age to MCI and AD.

Original languageEnglish
Pages (from-to)815-828
Number of pages14
JournalAnnals of Neurology
Volume55
Issue number6
DOIs
StatePublished - Jun 1 2004

Fingerprint

Tauopathies
Cholinergic Agents
Alzheimer Disease
Neurofibrillary Tangles
Neurons
Cholinergic Neurons
Choline O-Acetyltransferase
Cholinesterase Inhibitors
Denervation
Cognitive Dysfunction
Antibodies

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. / Mesulam, Marsel; Shaw, Pamela; Mash, Deborah C; Weintraub, Sandra.

In: Annals of Neurology, Vol. 55, No. 6, 01.06.2004, p. 815-828.

Research output: Contribution to journalArticle

Mesulam, Marsel ; Shaw, Pamela ; Mash, Deborah C ; Weintraub, Sandra. / Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. In: Annals of Neurology. 2004 ; Vol. 55, No. 6. pp. 815-828.
@article{b09d0a9adfb84dc4a88527c2c12a89cf,
title = "Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum",
abstract = "The cholinergic denervation in Alzheimer's disease (AD) provides the rationale for treatments with anticholinesterases. The presence of this cholinergic lesion is solidly established in advanced AD. Whether it also exists in early disease remains unsettled. This question was addressed with thioflavin-S histofluorescence to identify neurofibrillary tangles (NFT) and two tau antibodies (AT8, Alz-50) to identify pre-tangle cytopathology in the nucleus basalis, the source of cortical cholinergic innervation. Methods for the concurrent visualization of tauopathy and choline acetyltransferase were used to determine if the cytopathology was selectively located within cholinergic neurons. Five elderly index cases who had died at the stage of mild cognitive impairment (MCI) or early AD were identified by longitudinal neuropsychological and behavioral assessments. They were compared to 7 age-matched cognitively normal subjects. NFT and AT8 (or Alz-50) immunostaining in cholinergic nucleus basalis neurons existed even in the cognitively normal subjects. The percentage of tauopathy-containing nucleus basalis neurons was greater in the cognitively impaired and showed a significant correlation with memory scores obtained 1-18 months prior to death. These results show that cytopathology in cortical cholinergic pathways is a very early event in the course of the continuum that leads from advanced age to MCI and AD.",
author = "Marsel Mesulam and Pamela Shaw and Mash, {Deborah C} and Sandra Weintraub",
year = "2004",
month = "6",
day = "1",
doi = "10.1002/ana.20100",
language = "English",
volume = "55",
pages = "815--828",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum

AU - Mesulam, Marsel

AU - Shaw, Pamela

AU - Mash, Deborah C

AU - Weintraub, Sandra

PY - 2004/6/1

Y1 - 2004/6/1

N2 - The cholinergic denervation in Alzheimer's disease (AD) provides the rationale for treatments with anticholinesterases. The presence of this cholinergic lesion is solidly established in advanced AD. Whether it also exists in early disease remains unsettled. This question was addressed with thioflavin-S histofluorescence to identify neurofibrillary tangles (NFT) and two tau antibodies (AT8, Alz-50) to identify pre-tangle cytopathology in the nucleus basalis, the source of cortical cholinergic innervation. Methods for the concurrent visualization of tauopathy and choline acetyltransferase were used to determine if the cytopathology was selectively located within cholinergic neurons. Five elderly index cases who had died at the stage of mild cognitive impairment (MCI) or early AD were identified by longitudinal neuropsychological and behavioral assessments. They were compared to 7 age-matched cognitively normal subjects. NFT and AT8 (or Alz-50) immunostaining in cholinergic nucleus basalis neurons existed even in the cognitively normal subjects. The percentage of tauopathy-containing nucleus basalis neurons was greater in the cognitively impaired and showed a significant correlation with memory scores obtained 1-18 months prior to death. These results show that cytopathology in cortical cholinergic pathways is a very early event in the course of the continuum that leads from advanced age to MCI and AD.

AB - The cholinergic denervation in Alzheimer's disease (AD) provides the rationale for treatments with anticholinesterases. The presence of this cholinergic lesion is solidly established in advanced AD. Whether it also exists in early disease remains unsettled. This question was addressed with thioflavin-S histofluorescence to identify neurofibrillary tangles (NFT) and two tau antibodies (AT8, Alz-50) to identify pre-tangle cytopathology in the nucleus basalis, the source of cortical cholinergic innervation. Methods for the concurrent visualization of tauopathy and choline acetyltransferase were used to determine if the cytopathology was selectively located within cholinergic neurons. Five elderly index cases who had died at the stage of mild cognitive impairment (MCI) or early AD were identified by longitudinal neuropsychological and behavioral assessments. They were compared to 7 age-matched cognitively normal subjects. NFT and AT8 (or Alz-50) immunostaining in cholinergic nucleus basalis neurons existed even in the cognitively normal subjects. The percentage of tauopathy-containing nucleus basalis neurons was greater in the cognitively impaired and showed a significant correlation with memory scores obtained 1-18 months prior to death. These results show that cytopathology in cortical cholinergic pathways is a very early event in the course of the continuum that leads from advanced age to MCI and AD.

UR - http://www.scopus.com/inward/record.url?scp=2542511697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542511697&partnerID=8YFLogxK

U2 - 10.1002/ana.20100

DO - 10.1002/ana.20100

M3 - Article

VL - 55

SP - 815

EP - 828

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 6

ER -